P46361 11th Annual Pharma Regulatory Affairs Asia 2018
Download Brochure Request

Register your interest

Comments

Register your interest

Comments

11th Annual Pharma Regulatory Affairs Asia 2018

19 – 20 Sep 2018,  One Farrer Hotel & Spa, Singapore

Register Your Interest Download Brochure

SPECIAL 1-FOR-1 OFFER ON NORMAL RATES FOR PHARMACEUTICAL COMPANIES*
LIMITED SEATS, APPLICABLE ONLY TO 2-DAY MAIN CONFERENCE DAYS.
SEE PRICING BELOW FOR MORE INFORMATION.

overview

The 11thAnnual Pharma Regulatory Affairs Asia is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region. With a 10-year track record, IBC Asia brings to market the latest developments and key insights from decision makers.

Part of the 5th Annual PharmaCon Asia, meet and network with industry leaders and implementers, and get up-to-speed on the latest insights and case studies in pharma across 4 co-located events.

“The event was beneficial in understanding new therapy areas and challenges which are beyond generic pharmaceuticals.”

– Rakesh Chaurasia, Advisor, Strategic International Regulatory Affairs, PT Dexa Medica

Snapshot of 2018 Attendee List:

View »

Conference Highlights

  • Updates on the regulatory harmonization efforts in Asia for pharmaceutical drugs
  • Country-specific regulatory updates on the latest guidelines and initiatives
  • Global eCTD transition and acceleration in emerging markets and China
  • Use of AI in pharmaceutical regulatory operations
  • Enhancing launch excellence and cross-functional connections for better regulatory outcomes
  • Post-marketing surveillance requirements – best practices for compliance in managing post-approval changes, clinical research, safety
  • Global and regional outlook on drug e-labelling initiatives

Choose your language

Part of

Pharmacon Asia >>

Co-Located Events

Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Asia >>
Pharma Market Access and Pricing Summit Asia >>
Digital Pharma Summit >>

Sponsorship

Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>

speakers

Danny Soon

Senior Director, Health and Biomedical Cluster, Biomedical Research Council (BMRC) A*STAR

Ho Weng Si

Director, Biomedical Sciences Group, Economic Development Board, Singapore

Kurt Scheinpflug

Senior Director of Digital Medicines Engineering, Proteus Digital Health, USA

Enver Erkan

Country Manager, Pfizer Singapore

Alexis Serlin

Asia Cluster Head, Novartis

Miguel Rivera

Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland

How Ti-Hwei

Country President, AstraZeneca, Singapore

Shun Jin

Head, Regulatory Affairs, APMA, Sandoz, Singapore

Finny Liu

Lead of APAC Regional Regulatory Policy, PDR, Roche, Singapore

Hye Jin Choi

Principal, Strategic Clinical Development Consulting Asia Pacific, IQVIA, South Korea

Bruce Sun

Publishing Team Lead (Established Markets), Worldwide Regulatory Operations, Pfizer, China

Silke Nolkemper

General Manager, Director Consulting APAC, EXTEDO, China

Cindy Huang

Senior Technical Specialist, Division of Medicinal Products, Taiwan Food & Drug Administration, Taiwan

Chua Hui Ming

Senior Principal Assistant Director, Biologics Section, Center for Product Registration, National Pharmaceutical Regulatory Division (NPRA), Ministry of Health Malaysia

Theingi Zin

Director (Drug Control), Food & Drug Administration, Ministry of Health & Sports, Myanmar

Sherry Wang Biotech Investment Summit

Sherry Wang

Associate Director, Public Policy & Regulatory Affairs - Southeast Asia, Global External Affairs, United States Pharmacopeia (USP), Singapore

Koichi Miyazaki

Senior Director, Clinical Development Group, Asia Development Department, R&D Division, Daiichi Sankyo, Japan

Catherine Clemente

Associate Drug Regulatory Affairs & Pharmacovigilance Lead, Sandoz, Philippines

Lu Bihong

Head, Regulatory Affairs APAC, UCB Pharmaceuticals, China

May Wei

Vice President, Head of Regulatory, CMC & Production, Moleac, Singapore

Anuradha Arunachalam

Regulatory Affairs and Pharmacovigilance Specialist, Novo Nordisk, Singapore

Jean-Christophe Delumeau

Head of Pharmacovigilance Policy Strategy, Bayer, Singapore

Rie Matsui

Director, Regional Labeling Head for Asia, Pfizer, Japan

Yeo Jing Ping

Director of Research Integrity, Compliance & Ethics, SingHealth, Singapore

Manoj Saxena

Director Regional Market Access, Asia-Pacific, Bayer, Singapore

Hazel Dy Tioco

Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Yaron Turpaz

Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

Harish Dave

Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

when & where

19 - 20 Sep 2018

One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

contact

Still have a question?

Speaking Opportunities
Genevieve Lim
+65-6508 2472
 
Genevieve.Lim@ibcasia.com.sg

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489

Yvonne.Leong@ibcasia.com.sg

Media & Association Partnership Opportunities
June Tan
+65 6508 2465
June.Tan@ibcasia.com.sg

sponsors

exhibitors

STAY UPDATED ON OUR NEWS & EVENTS

IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more